162 related articles for article (PubMed ID: 23852271)
1. Do C1q or IgM nephropathies predict disease severity in children with minimal change nephrotic syndrome?
Vintar Spreitzer M; Vizjak A; Ferluga D; Kenda RB; Kersnik Levart T
Pediatr Nephrol; 2014 Jan; 29(1):67-74. PubMed ID: 23852271
[TBL] [Abstract][Full Text] [Related]
2. C1q nephropathy and minimal change nephrotic syndrome.
Wong CS; Fink CA; Baechle J; Harris AA; Staples AO; Brandt JR
Pediatr Nephrol; 2009 Apr; 24(4):761-7. PubMed ID: 19082635
[TBL] [Abstract][Full Text] [Related]
3. C1q nephropathy in children: clinical characteristics and outcome.
Gunasekara VN; Sebire NJ; Tullus K
Pediatr Nephrol; 2014 Mar; 29(3):407-13. PubMed ID: 24326785
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of IgM and C1q deposition in the mesangium in pediatric idiopathic nephrotic syndrome.
Kanemoto K; Ito H; Anzai M; Matsumura C; Kurayama H
J Nephrol; 2013; 26(2):306-14. PubMed ID: 22641570
[TBL] [Abstract][Full Text] [Related]
5. C1q nephropathy: a variant of focal segmental glomerulosclerosis.
Markowitz GS; Schwimmer JA; Stokes MB; Nasr S; Seigle RL; Valeri AM; D'Agati VD
Kidney Int; 2003 Oct; 64(4):1232-40. PubMed ID: 12969141
[TBL] [Abstract][Full Text] [Related]
6. Glomerulopathy with mesangial IgM deposits: long-term follow up of 64 children.
Zeis PM; Kavazarakis E; Nakopoulou L; Moustaki M; Messaritaki A; Zeis MP; Nicolaidou P
Pediatr Int; 2001 Jun; 43(3):287-92. PubMed ID: 11380926
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance and long-term evolution of minimal change histopathologic variants and of IGM nephropathy among Egyptians.
Donia AF; Sobh MA; Moustafa FE; Bakr MA; Foda MA
J Nephrol; 2000; 13(4):275-81. PubMed ID: 10946807
[TBL] [Abstract][Full Text] [Related]
8. The clinical significance of mesangial IgM deposits and mesangial hypercellularity in minimal change nephrotic syndrome.
Pardo V; Riesgo I; Zilleruelo G; Strauss J
Am J Kidney Dis; 1984 Jan; 3(4):264-9. PubMed ID: 6691342
[TBL] [Abstract][Full Text] [Related]
9. In vitro B-lymphocyte switch disturbance from IgM into IgG in IgM mesangial nephropathy.
Lin CY; Chen CH; Lee PP
Pediatr Nephrol; 1989 Jul; 3(3):254-8. PubMed ID: 2702103
[TBL] [Abstract][Full Text] [Related]
10. Pathology, clinical presentations, and outcomes of C1q nephropathy.
Vizjak A; Ferluga D; Rozic M; Hvala A; Lindic J; Levart TK; Jurcić V; Jennette JC
J Am Soc Nephrol; 2008 Nov; 19(11):2237-44. PubMed ID: 18650484
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of IgM deposition in the mesangium and mesangial hypercellularity in adult minimal change nephrotic syndrome].
Maruyama M; Toyoda M; Umezono T; Miyauchi M; Yamamoto N; Kimura M; Honma M; Nishina M; Endoh M; Sakai H; Suzuki D
Nihon Jinzo Gakkai Shi; 2006; 48(1):14-21. PubMed ID: 16480062
[TBL] [Abstract][Full Text] [Related]
12. Minimal change disease with IgM+ immunofluorescence: a subtype of nephrotic syndrome.
Swartz SJ; Eldin KW; Hicks MJ; Feig DI
Pediatr Nephrol; 2009 Jun; 24(6):1187-92. PubMed ID: 19219463
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic correlation and outcome of C1q nephropathy.
Hisano S; Fukuma Y; Segawa Y; Niimi K; Kaku Y; Hatae K; Saitoh T; Takeshita M; Iwasaki H
Clin J Am Soc Nephrol; 2008 Nov; 3(6):1637-43. PubMed ID: 18650410
[TBL] [Abstract][Full Text] [Related]
14. The Clinical Impact of Glomerular Immunoglobulin M Deposition in Patients with Type 2 Diabetic Nephropathy.
Tang X; Li H; Li L; Zhang J; Xu H; Li L; Liu F
Am J Med Sci; 2018 Oct; 356(4):365-373. PubMed ID: 30360805
[TBL] [Abstract][Full Text] [Related]
15. The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series.
Maas RJ; Deegens JK; Beukhof JR; Reichert LJ; Ten Dam MA; Beutler JJ; van den Wall Bake AWL; Rensma PL; Konings CJ; Geerse DA; Feith GW; Van Kuijk WH; Wetzels JF
Am J Kidney Dis; 2017 May; 69(5):637-646. PubMed ID: 28089478
[TBL] [Abstract][Full Text] [Related]
16. C1Q nephropathy in children.
Kersnik Levart T; Kenda RB; Avgustin Cavić M; Ferluga D; Hvala A; Vizjak A
Pediatr Nephrol; 2005 Dec; 20(12):1756-61. PubMed ID: 16247648
[TBL] [Abstract][Full Text] [Related]
17. [MCNS, which secondary developed into incidental IgA nephropathy--a case report].
Tsunehisa N; Takemura T; Inui T; Kamiya H
Nihon Jinzo Gakkai Shi; 1992 Oct; 34(10):1095-9. PubMed ID: 1289609
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic correlation of C1q nephropathy in children.
Fukuma Y; Hisano S; Segawa Y; Niimi K; Tsuru N; Kaku Y; Hatae K; Kiyoshi Y; Mitsudome A; Iwasaki H
Am J Kidney Dis; 2006 Mar; 47(3):412-8. PubMed ID: 16490619
[TBL] [Abstract][Full Text] [Related]
19. A clinicopathological study of C1q nephropathy at King Abdulaziz University.
Mokhtar GA; Jalalah SM
Iran J Kidney Dis; 2015 Jul; 9(4):279-85. PubMed ID: 26174454
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of interleukin-4--related genes in Japanese children with minimal change nephrotic syndrome.
Kobayashi Y; Arakawa H; Suzuki M; Takizawa T; Tokuyama K; Morikawa A
Am J Kidney Dis; 2003 Aug; 42(2):271-6. PubMed ID: 12900808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
